Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0A0ZW
|
|||
Drug Name |
ARN-6039
|
|||
Synonyms |
BOS172767
Click to Show/Hide
|
|||
Indication | Multiple sclerosis [ICD-11: 8A40; ICD-9: 340] | Phase 1 | [1] | |
Psoriasis vulgaris [ICD-11: EA90; ICD-9: 696] | Phase 1 | [1] | ||
Company |
Arrien Pharmaceuticals Salt Lake City, UT Boston Pharmaceuticals Cambridge, MA
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Nuclear receptor ROR-gamma (RORG) | Target Info | Agonist | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.